A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Clinical trial NCT00105443 · COMPLETED

Trial details

NCT number: NCT00105443
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2005-03-01
Primary completion: 2008-11-01
Enrollment: 602

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.